tiprankstipranks
Trending News
More News >
KP Tissue Inc. (TSE:KPT)
TSX:KPT
Canadian Market

KP Tissue (KPT) Earnings Dates, Call Summary & Reports

Compare
109 Followers

Earnings Data

Report Date
May 07, 2026
Before Open (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.23
Last Year’s EPS
0.14
Same Quarter Last Year
Based on 2 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 18, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: double-digit adjusted EBITDA growth, revenue gains, market-share expansion in Canada, a net income turnaround and improved liquidity and leverage. Challenges include modest sequential softness in revenue and EBITDA, rising operating and SG&A costs, pulp price volatility with potential upward pressure in 2026, and higher planned CapEx with possible short-term leverage increases tied to a new TAD project. On balance, the positive performance metrics and strategic progress outweigh the near-term headwinds.
Company Guidance
Management guided Q1 2026 adjusted EBITDA to be in a similar range to Q4 2025 (Q4 adjusted EBITDA $84.2M; run rate above $80M for a second consecutive quarter) with consolidated adjusted EBITDA margin ~15% (consumer margin 16.5%, AFH margin 11%). They raised 2026 CapEx to $100–$120M (FY2025 CapEx $78M; Q4 CapEx $33.4M), with base CapEx ~$50–70M, Line 11 spending $25–35M and a small amount of first‑year TAD project spend. The new converting line in Memphis is on track for early Q2 2026 start, a proposed Western U.S. TAD plant is slated to open in 2028 with a detailed announcement expected H1 2026, and financing could push leverage briefly above 4x (current leverage 3.1x; long‑term debt $1.741B; cash $196.1M; net debt reduced by $55.7M). Management will monitor pulp and other input costs (Q4 pulp QoQ range -6.6% to +3.3%; NBSK -7.3% YoY; BEK -5.3% YoY) and use its pricing model to respond as needed.
Adjusted EBITDA Growth and Margin Improvement
Q4 adjusted EBITDA of $84.2M, up 26% year-over-year; adjusted EBITDA margin improved to 15.0% from 12.4% a year ago; run-rate above $80M for a second consecutive quarter.
Revenue Growth
Q4 consolidated revenue of $560.1M, up 3.8% year-over-year (described as nearly 4%); full fiscal 2025 revenue growth of 7.5%.
Net Income Turnaround
Q4 net income of $23.4M versus a net loss of $13.7M in Q4 2024; improvement driven by favorable foreign exchange of $29.7M and higher adjusted EBITDA of $17.4M (partially offset by tax, interest and noncontrolling interest impacts).
Geographic Performance — Canada and U.S.
Canada Q4 revenue +5.1% (approx. +$15M); U.S. Q4 revenue +2.2% (approx. +$5.5M) despite a strong prior-year comparable; U.S. annual growth rate of 8.2%, identified as the company’s growth engine.
Strong Consumer and AFH Segment Results
Consumer revenue $472.3M, up 4.3% YoY; consumer adjusted EBITDA $78.1M with a 16.5% margin (improvement of ~2 percentage points YoY). Away-From-Home revenue $87.8M, up 1% YoY; AFH adjusted EBITDA $9.7M vs $4.6M YoY, AFH margin ~11% (more than doubled year-over-year).
Market Share Gains in Canada
Facial tissue market share increased by 130 basis points to 46.3% (52-week period ended Dec 27, 2025); paper towel share grew 130 basis points to 25.3%; bathroom tissue showed incremental year-over-year growth.
Operational Progress and Safety
Positive production rates across paper machine and converting operations; Memphis converting line on track for startup in early Q2 2026; Sherbrooke in-sourcing improved AFH margins; record safety results across manufacturing assets in 2025.
Balance Sheet and Liquidity Improvement
Cash improved to $196.1M from $149.1M at end of Q3; long-term debt of $1.741B decreased $9.4M sequentially; net debt reduced by $55.7M; leverage ratio declined to 3.1x from 3.4x.

KP Tissue (TSE:KPT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:KPT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 07, 2026
2026 (Q1)
0.23 / -
0.135
Feb 18, 2026
2025 (Q4)
0.25 / 0.60
0.34475.29% (+0.26)
Nov 13, 2025
2025 (Q3)
0.14 / 0.84
-0.818202.20% (+1.65)
Aug 13, 2025
2025 (Q2)
0.12 / -1.36
0.516-363.95% (-1.88)
May 14, 2025
2025 (Q1)
0.09 / 0.14
1.097-87.69% (-0.96)
Mar 05, 2025
2024 (Q4)
0.15 / 0.34
-0.819142.00% (+1.16)
Nov 13, 2024
2024 (Q3)
0.14 / -0.82
0.32-355.62% (-1.14)
Aug 13, 2024
2024 (Q2)
0.19 / 0.52
0.3261.25% (+0.20)
May 14, 2024
2024 (Q1)
0.11 / 1.10
-0.998209.92% (+2.09)
Mar 07, 2024
2023 (Q4)
0.18 / -0.82
0.24-441.25% (-1.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:KPT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 18, 2026
C$10.64C$10.68+0.38%
Nov 13, 2025
C$9.42C$9.50+0.85%
Aug 13, 2025
C$9.26C$9.32+0.64%
May 14, 2025
C$8.07C$8.18+1.31%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does KP Tissue Inc. (TSE:KPT) report earnings?
KP Tissue Inc. (TSE:KPT) is schdueled to report earning on May 07, 2026, Before Open (Confirmed).
    What is KP Tissue Inc. (TSE:KPT) earnings time?
    KP Tissue Inc. (TSE:KPT) earnings time is at May 07, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:KPT EPS forecast?
          TSE:KPT EPS forecast for the fiscal quarter 2026 (Q1) is 0.23.